Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sodium acetate
Drug ID BADD_D02032
Description Sodium Acetate is chemically designated CH3COONa, a hygroscopic powder very soluble in water. Sodium acetate could be used as additives in food, industry, concrete manufacture, heating pads and in buffer solutions. Medically, sodium acetate is important component as an electrolyte replenisher when given intravenously. It is mainly indicated to correct sodium levels in hyponatremic patients. It can be used also in metabolic acidosis and for urine alkalinization.
Indications and Usage Injection, USP 40 mEq is indicated as a source of sodium, for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. Sodium acetate and other bicarbonate precursors are alkalinising agents, and can be used to correct metabolic acidosis, or for alkalinisation of the urine.
Marketing Status Prescription
ATC Code B05XA08
DrugBank ID DB09395
KEGG ID D01779
MeSH ID D019346
PubChem ID 517045
TTD Drug ID Not Available
NDC Product Code 0517-5023; 70387-125; 0409-3299; 55897-003; 63323-032; 55897-001; 0409-7299; 49452-6550; 69784-230; 69784-231
Synonyms Sodium Acetate | Sodium Acetate Trihydrate | Sodium Acetate, Anhydrous
Chemical Information
Molecular Formula C2H3NaO2
CAS Registry Number 126-96-5
SMILES CC(=O)[O-].[Na+]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Asthenia08.01.01.001--Not Available
Blood sodium abnormal13.11.01.025--Not Available
Body temperature increased13.15.01.001--Not Available
Cellulitis23.09.01.001; 11.02.01.001--Not Available
Coma17.02.09.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Dehydration14.05.05.001--
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
Dyspnoea22.02.01.004; 02.01.03.002--
Extravasation08.01.03.008--Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Headache17.14.01.001--
Heart rate irregular13.14.04.003--Not Available
Hypernatraemia14.05.04.001--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Hypokalaemia14.05.03.002--
Irritability19.04.02.013; 08.01.03.011--
Metabolic alkalosis14.01.02.004--Not Available
Mood swings19.04.03.001--Not Available
Muscle twitching15.05.03.005--Not Available
Muscular weakness17.05.03.005; 15.05.06.001--
Respiratory failure22.02.06.002; 14.01.04.003--
Salivary hypersecretion07.06.01.009--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.007--Not Available
Tetany15.05.03.013; 14.04.01.005; 05.04.02.003--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages